Abstract
Objectives
To evaluate the outcome of salvage surgery following definitive chemoradiotherapy (CRT) for locally advanced esophageal cancer.
Methods
We reviewed patients undergoing salvage esophagectomy from August 2000 through April 2006 at the National Cancer Center Hospital East, following 5-fluorouracil and cisplatinum chemotherapy with concurrent radiotherapy over 50 Gy. Clinicopathological backgrounds, complications, and survival were analyzed.
Results
Forty-six patients (42 men, all with squamous cell carcinoma) underwent salvage surgery after full-dose concurrent chemoradiotherapy. The median age was 61 years (range, 43–72). Thirteen patients had a relapse after complete response; 26 patients partial response; 4 patients progressive disease; 3 patients NC to CRT. Salvage surgery consisted of transthoracic esophagectomy, three-field node dissection, and reconstruction with the colon or stomach with vascular restoration. Operation time ranged from 257 to 602 min. Postoperative complications were pneumonia in 5; anastmotic leakage in 10; wound infection in 3; anastomotic stenosis in 2; recurrent nerve palsy in 4; pyothorax in 2; multiple organ failure in 1; myocardial infarction in 1; trachea necrosis in 1. There were four 30-day operative deaths and three more hospital deaths. The median survival time from salvage surgery was 12 months and that from CRT was 22 months. The 3-year survival rate was 17%. Three patients are surviving more than 3 years and their diseases were pathological N0.
Conclusion
Mobidity and mortality rates were high among patients undergoing salvage esophagectomy. However, there are some long-term survivors, and highly selected patients should be indicated for salvage surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
JS Cooper MD Guo A Herskovic JS Macdonald JA Martenson SuffixJr M Al-Sarraf et al. (1999) ArticleTitleChemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group JAMA 281 1623–7 Occurrence Handle10235156 Occurrence Handle10.1001/jama.281.17.1623 Occurrence Handle1:STN:280:DyaK1M3kvFagtw%3D%3D
A Herskovic K Martz M Al-Sarraf L Leichman J Brindle V Vaitkevicius et al. (1992) ArticleTitleCombined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 1593–8 Occurrence Handle1584260 Occurrence Handle1:STN:280:DyaK383mtFKkuw%3D%3D Occurrence Handle10.1056/NEJM199206113262403
S Hironaka A Ohtsu N Boku M Muto F Nagashima H Saito et al. (2003) ArticleTitleNonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus Int J Radiat Oncol Biol Phys 57 425–33 Occurrence Handle12957254 Occurrence Handle10.1016/S0360-3016(03)00585-6
M Goldberg J Farma C Lampert P Colarusso L Coia H Frucht (2003) ArticleTitleSurvival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: a phase I report J Thorac Cardiovasc Surg 126 1168–73 Occurrence Handle14566264 Occurrence Handle10.1016/S0022-5223(03)00977-2 Occurrence Handle1:CAS:528:DC%2BD3sXpsVSjsLY%3D
CD Wright JC Wain TJ Lynch NC Choi ML Grossbard RW Carey et al. (1997) ArticleTitleInduction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study J Thorac Cardiovasc Surg 114 811–5 Occurrence Handle9375611 Occurrence Handle10.1016/S0022-5223(97)70085-0 Occurrence Handle1:CAS:528:DyaK2sXnslyltb4%3D
MS Bains A Stojadinovic B Minsky V Rusch A Turnbull R Korst et al. (2002) ArticleTitleA phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results J Thorac Cardiovasc Surg 124 270–7 Occurrence Handle12167786 Occurrence Handle10.1067/mtc.2002.122545 Occurrence Handle1:CAS:528:DC%2BD38XntFert7s%3D
SG Swisher P Wynn JB Putnam MB Mosheim AM Correa RR Komaki et al. (2002) ArticleTitleSalvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy J Thorac Cardiovasc Surg 123 IssueID1 175–83 Occurrence Handle11782772 Occurrence Handle10.1067/mtc.2002.119070
JB Dimick PJ Pronovost JA Cowan PA Lipsett (2003) ArticleTitleSurgical volume and quality of care for esophageal resection: do high-volume hospitals have fewer complications? Ann Thorac Surg 75 IssueID2 337–41 Occurrence Handle12607635 Occurrence Handle10.1016/S0003-4975(02)04409-0
Author information
Authors and Affiliations
Corresponding author
Additional information
Presented at the 59th Annual Scientific Meeting of the Japanese Association for Thoracic Surgery, held in Tokyo, Japan, October 1–4, 2006
Rights and permissions
About this article
Cite this article
Nishimura, M., Daiko, H., Yoshida, J. et al. Salvage esophagectomy following definitive chemoradiotherapy. Gen Thorac Cardiovasc Surg 55, 461–465 (2007). https://doi.org/10.1007/s11748-007-0157-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-007-0157-z